Inactive

The purpose of this sole source award to Siga Tecnologies Inc., is to replenish existing Force Health Protection quantities of TPOXX, an oral Small Pox Treatmentcapsule, approved by the US FDA in 2018... The purpose of this sole source award to Siga Tecnologies Inc., is to replenish existing Force Health Protection quantities of TPOXX, an oral Small Pox Treatmentcapsule, approved by the US FDA in 2018.